IRS
ZBH icon

Invictus RG (Singapore)’s Zimmer Biomet ZBH Stock Holding History

Invictus RG (Singapore)’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-104
Closed -$11K – 718
2015
Q2 		$11K Buy
+104
New +$11.5K 0.01% 552

Other funds holding ZBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invictus RG (Singapore)'s ZBH Position: Q3 2015 in Review

Invictus RG (Singapore) sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 104 shares — an estimated $11K sold.

Invictus RG (Singapore) first reported a position in ZBH in Q2 2015 and held it in 1 quarter. The position peaked at $11K in Q2 2015. 726 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

  • Invictus RG (Singapore) reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
  • Invictus RG (Singapore) sold 104 Zimmer Biomet shares in Q3 2015, an estimated $11K.
  • Invictus RG (Singapore) first reported a position in Zimmer Biomet in Q2 2015 and held it in 1 quarter.
  • Invictus RG (Singapore)'s Zimmer Biomet position peaked at $11K in Q2 2015.
  • 726 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q3 2015, filed 13 Nov 2015.